Home › Funds › BROOKTREE CAPITAL MANAGEMENT › WST
BROOKTREE CAPITAL MANAGEMENT position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
BROOKTREE CAPITAL MANAGEMENT reported holding 4,353 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.11% of its reported portfolio and ranking #20 among its reported holdings. BROOKTREE CAPITAL MANAGEMENT has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BROOKTREE CAPITAL MANAGEMENT's WST position evolved
BROOKTREE CAPITAL MANAGEMENT first disclosed a stake in WST in Q3 2023 at 4,741 shares (US$1.8M). The position peaked in Q1 2024 at 4,663 shares, worth US$1.8M. Across 13 filings, BROOKTREE CAPITAL MANAGEMENT increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,353 shares valued at US$1.6M — an increase of 24 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.74K | $1.78M | New |
| Q4 2023 | 4.48K | $1.58M | Reduce |
| Q1 2024 | 4.66K | $1.85M | Add |
| Q2 2024 | 4.46K | $1.47M | Reduce |
| Q3 2024 | 4.60K | $1.38M | Add |
| Q4 2024 | 4.59K | $1.50M | Hold |
| Q1 2025 | 4.74K | $1.06M | Add |
| Q2 2025 | 4.92K | $1.08M | Add |
| Q3 2025 | 5.30K | $1.39M | Add |
| Q4 2025 | 5.16K | $1.42M | Reduce |
| Q1 2026 | 4.37K | $1.10M | Reduce |
| Q2 2026 | 4.33K | $1.55M | Reduce |
| Q3 2026 | 4.35K | $1.61M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WST and 13F data
WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WST
- Artisan Partners Limited Partnership 2.01M sh · $744.42M · Q3 2026
- GENERATION INVESTMENT MANAGEMENT LLP 2.03M sh · $728.17M · Q2 2026
- BROWN ADVISORY INC 1.08M sh · $386.04M · Q2 2026
- Longview Partners (Guernsey) LTD 1.03M sh · $371.14M · Q2 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 760.62K sh · $273.06M · Q2 2026
More on BROOKTREE CAPITAL MANAGEMENT
FAQ
How long has BROOKTREE CAPITAL MANAGEMENT held WST?
BROOKTREE CAPITAL MANAGEMENT has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BROOKTREE CAPITAL MANAGEMENT's current position in WST?
As of Q3 2026, BROOKTREE CAPITAL MANAGEMENT holds 4.35K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $1.61M, representing 1.11% of its reported portfolio and ranking #20.
Has BROOKTREE CAPITAL MANAGEMENT been buying or selling WST?
In the latest 13F filing (Q3 2026), BROOKTREE CAPITAL MANAGEMENT increased its position in WST. The position peaked in Q1 2024 at 4.66K shares.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.